CJC-1295 + Ipamorelin
Peptide-blend reference combining a GHRH analog (CJC-1295) with a ghrelin-receptor agonist (ipamorelin); evidence exists for the components individually.
Composition
Composition pending verification
Technical Dossier
Batch / Lot Number
—
Testing Status
—
Testing Laboratory
—
Test Date
—
Classification
Peptide blend: GHRH analog (CJC-1295) + GHRP / ghrelin-receptor agonist (ipamorelin)
Mechanism / Biological Target
Research Areas
Research Overview
Laboratory Storage & Handling
References
- Ipamorelin, the first selective growth hormone secretagogue
Raun K, et al. European Journal of Endocrinology, 1998.
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin in healthy volunteers
Clinical Pharmacology / human PK-PD, 1999.
- Prolonged stimulation of GH and IGF-I secretion by CJC-1295 (with DAC)
Journal of Clinical Endocrinology & Metabolism, 2006.
Available Documentation
- Certificate of AnalysisPending / Not yet available
For Research Use Only
Compounds referenced on Peptide Underground are intended for laboratory and research purposes only. They are not intended to diagnose, treat, cure, or prevent any disease and are not intended for human consumption.